SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-370277
Filing Date
2015-11-06
Accepted
2015-11-06 16:51:39
Documents
13
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d72579d10q.htm 10-Q 515979
2 EX-10.1 d72579dex101.htm EX-10.1 440543
3 EX-10.2 d72579dex102.htm EX-10.2 316706
4 EX-10.3 d72579dex103.htm EX-10.3 66080
5 EX-31.1 d72579dex311.htm EX-31.1 9201
6 EX-31.2 d72579dex312.htm EX-31.2 9495
7 EX-32.1 d72579dex321.htm EX-32.1 4779
  Complete submission text file 0001193125-15-370277.txt   5513017

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT aria-20150930.xml EX-101.INS 779114
9 XBRL TAXONOMY EXTENSION SCHEMA aria-20150930.xsd EX-101.SCH 62039
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aria-20150930_cal.xml EX-101.CAL 75921
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aria-20150930_def.xml EX-101.DEF 358356
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE aria-20150930_lab.xml EX-101.LAB 484856
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aria-20150930_pre.xml EX-101.PRE 425749
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36172 | Film No.: 151213014
SIC: 2836 Biological Products, (No Diagnostic Substances)